CTOs on the Move

EvidenceCare

www.evidence.care

 
EvidenceCare is the only decision support tool designed exclusively for clinicians that delivers evidence-based medicine individualized for each patient they treat. Our patent pending technology lowers costs and improves outcomes in a way that benefits patients, providers, payers, and clinics. We provide the evidence, so you can provide the care.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.evidence.care
  • 1550 West McEwen Drive Suite 60
    Franklin, TN USA 37067
  • Phone: 877.646.6846

Executives

Name Title Contact Details

Similar Companies

Duos

DUOS is reimagining freedom at any age. As a technology-enabled service provider, DUOS connects people to the essential resources required to attain the highest level of health. Our advanced technology allows us to aggregate historically siloed data and resources from across the ecosystem, breaking down barriers to health literacy and access to care and enabling seamless and timely connections with complete visibility and feedback throughout the process.

Chancellor Health Trust

Chancellor Health Trust is a Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Better Health Group

Better Health Group is a national primary care platform that enables providers to shift focus to value-based care. They take a proactive approach by focusing on preventing disease rather than just treating symptoms.

The Schwartz Group

The Schwartz Group is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.